Cardioprotective effects of deferoxamine in acute and subacute cardiotoxicities of doxorubicin: a randomized clinical trial

Abstract Background Cardiotoxicity is a major concern following doxorubicin (DOX) use in the treatment of malignancies. We aimed to investigate whether deferoxamine (DFO) can prevent acute cardiotoxicity in children with cancer who were treated with DOX as part of their chemotherapy. Results Sixty-t...

Full description

Bibliographic Details

Published in:	The Egyptian Heart Journal
Main Authors:	Kosar Rahimi, Hamid Amoozgar, Soheila Zareifar, Mahdi Shahriari, Omid Reza Zekavat, Mehran Karimi, Gholamreza Fathpour, Fazl Saleh, Nader Shakibazad, Shayan Bordbar, Mohammadreza Bordbar
Format:	Article
Language:	English
Published:	SpringerOpen 2023-03-01
Subjects:	Cancer Cardiotoxicity Deferoxamine Doxorubicin Pediatric
Online Access:	https://doi.org/10.1186/s43044-023-00347-4